Equity Fund L.P. Cardinal Sells 50,305 Shares of Guardian Pharmacy Services (NYSE:GRDN) Stock

Key Points

• Equity Fund L.P. Cardinal sold 50,305 shares of Guardian Pharmacy Services at an average price of $20.16, resulting in a total transaction value of $1,014,148.80, and a 25.14% decrease in their ownership.
• Guardian Pharmacy Services saw an upgrade from a "hold" to a "strong-buy" rating by Wall Street Zen, with a current consensus price target of $26.33 according to recent analyst reports.
• Significant institutional investment activity occurred in the second quarter, with new and increased positions from firms like TimesSquare Capital Management and Franklin Resources totaling millions in investment.

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) major shareholder Equity Fund L.P. Cardinal sold 50,305 shares of the company's stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $20.16, for a total value of $1,014,148.80. Following the completion of the transaction, the insider owned 149,794 shares in the company, valued at $3,019,847.04. This represents a 25.14% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Major shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.

Guardian Pharmacy Services Price Performance

GRDN traded up $0.19 during trading hours on Tuesday, reaching $26.26. The company's stock had a trading volume of 354,854 shares, compared to its average volume of 200,214. Guardian Pharmacy Services, Inc. has a fifty-two week low of $16.10 and a fifty-two week high of $30.39. The stock has a market cap of $1.66 billion and a PE ratio of -17.28. The business's 50-day moving average is $24.68 and its 200-day moving average is $22.96.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in GRDN. TimesSquare Capital Management LLC acquired a new position in Guardian Pharmacy Services during the second quarter worth $17,351,000. Franklin Resources Inc. lifted its stake in Guardian Pharmacy Services by 32.2% during the second quarter. Franklin Resources Inc. now owns 976,207 shares of the company's stock worth $20,803,000 after purchasing an additional 237,630 shares in the last quarter. Boston Partners acquired a new position in Guardian Pharmacy Services during the second quarter worth $4,227,000. Geode Capital Management LLC lifted its stake in Guardian Pharmacy Services by 65.9% during the second quarter. Geode Capital Management LLC now owns 336,701 shares of the company's stock worth $7,177,000 after purchasing an additional 133,715 shares in the last quarter. Finally, Sei Investments Co. lifted its stake in Guardian Pharmacy Services by 227.2% during the second quarter. Sei Investments Co. now owns 181,481 shares of the company's stock worth $3,867,000 after purchasing an additional 126,008 shares in the last quarter.

Analyst Upgrades and Downgrades

GRDN has been the topic of a number of recent analyst reports. Wall Street Zen upgraded Guardian Pharmacy Services from a "hold" rating to a "strong-buy" rating in a report on Sunday, August 17th. Truist Financial upped their price objective on Guardian Pharmacy Services from $28.00 to $30.00 and gave the company a "buy" rating in a report on Friday. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $26.33.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.